Clinical trial
Irbesartan in Mild to Moderate Hypertensive Patients
NCT00335673 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Irbesartan in Mild to Moderate Hypertensive Patients
- Lead sponsor
- Sanofi
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2006
- Completion date
- November 30, 2006
- Enrollment
- 1,630 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.